Navigation Links
Stereotaxis to Present at the Deutsche Bank 33rd Annual Health Care Conference
Date:5/1/2008

ST. LOUIS, May 1 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS), announced today that Bevil J. Hogg, Chief Executive Officer, and James M. Stolze, Chief Financial Officer, will present at the Deutsche Bank 33rd Annual Health Care Conference in Boston on Wednesday, May 7, 2008 at 8:50 a.m. Eastern Time.

Attendance at the conference is by invitation only. The audio presentation will be webcast live and remain available for 90 days at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=STXS&item_id=18275 65.

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe and Canada.


'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases
2. Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
3. Stereotaxis Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
4. Stereotaxis to Present at the Deutsche Bank Small- and Mid-Cap Growth Conference
5. Stereotaxis Receives $20 Million in Additional Loan Commitments
6. Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook
7. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
8. Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System
9. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
10. Kensey Nash to Present at the Bank of America 2008 Health Care Conference
11. Shire to present ADHD treatments scientific data at American Psychiatric Assoc. Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...t-traumatic stress disorder (PTSD) affects as many...rowing experience like rape, assault, war or terro...11 and broken up survivors, families. , There i... chance of developing the disorder, but thanks to ...of preventing PTSD may be just around the corner. ...
(Date:12/1/2008)...RIA, Va., Dec. 1 Today,... nearly 7,000 people die each day due to HIV/AID... of awareness and outreach to help people worldwid...me for World AIDS Day 2008 is You Can Make a Dif...ing people together to talk about HIV as well as h...
(Date:12/1/2008)..., Dec. 1 Blue Cross Blue Shield of...d financial and membership information,today to M...quest for further,information about Michigan,s in...n confirms growth of Michigan,s individual health ...suffered by BCBSM, the state,s last-resort,insura...
(Date:12/1/2008)..., Dec. 1 Condell Health...nter, a 283-bed hospital in Libertyville - after v...dicare and Medicaid payments - has agreed without ...of Illinois$36 million as a result of filing false...tzgerald, U.S. Attorney for the Northern District ...
Breaking Medicine News(10 mins):Health News:Easing the stress of trauma 2Health News:In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 2Health News:Blue Cross Blue Shield of Michigan Answers Attorney General 3Health News:Condell Health Network and Medical Center to Pay $36 Million Settlement After Self-Reporting Possible Health-Care Fraud 2
...erous health benefits and is being touted as a new...is welcome.Nicolas G. Bazan, MD, PhD, Boyd Profess...xcellence at LSU Health Sciences Centre in New Orl...ga-3 fatty acids in fish oil play in protecting ce...
...n increase in the number of babies born in the hou...d there were 15,198 home births// in 2004. The gro...ia had the lowest rates of home birth, and Devon h...d that women could not have a home birth. Even doc...
...preliminary study in humans are to be believed, re...nd out as part of a research// which appears in th...ion. In a statement by co-author Dr. Eric Ravussi...Baton Rouge, "A lot of evidence already exists to ...
...seas doctors in Britain are alarmed as new rules ...work permit before they can work// in hospitals of...rrently thousands of doctors from the Indian subc...selves unemployed. In the event of a job vacancy i...
Other Medicine News:Health News:Cut down on food to live longer!!! 2Health News:Work Permit Required For Indian Doctors in Britain 2Health News:Work Permit Required For Indian Doctors in Britain 3
(Date:11/27/2008)... of acute lymphoblastic leukemia relapse cases ari...nosis , , MEMPHIS, Tenn., Nov. 27 /PRNewswi...s Research Hospital have identified distinctive ge... acute lymphoblastic leukemia (ALL) that cause rel...eatments for ALL relapse in children and, ultimate...
(Date:11/26/2008)...ts , , FRANKLIN, Mass., Nov. 26 /PRNewswire...d: PLCSF) announced today that it has received ful...ion (FDA) for its U.S. pivotal trial to study the ...M) and associated therapy in the prevention of Co...DA also approved PLC,s request to expand their inv...
(Date:11/25/2008)...nts against expanding statin use broadly in wake o...., Nov. 25 JUPITER, a clinical tri...cular risk of healthy patients with elevated CRP, ...ults, according to a national poll directed at hea...rt in the online poll conducted by medical news si...
(Date:11/25/2008)...PRNewswire-FirstCall/ -- Pharmacyclics, Inc.,(Nas... completed a Phase 1,clinical trial with PCI-2748...cule Factor VIIa inhibitor. The trial was conducte...the safety and pharmacologic effect of,PCI-27483....a linear dose,response in the International Norma...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Choose Biodegradable Sunscreen to Save Coral Reefs 11459 1Choose Biodegradable Sunscreen to Save Coral Reefs 11459 2U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 1U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 2U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 3Predictors of inaccurate online breast cancer information 11452 1Predictors of inaccurate online breast cancer information 11452 2How red blood cells nuke their nuclei 11448 1How red blood cells nuke their nuclei 11448 2
...rmaceutical Co, Ltd. Sponsored Study,Presented at ...g -, SAN DIEGO, May 23, 2007 /PRNewswire/ -- In a ...ith schizophrenia, the Otsuka,Pharmaceutical Co., ...ipsychotic aripiprazole demonstrated significant i...cacy endpoint, Positive and,Negative Syndrome Scal...
...se 1 Studies with Monoclonal Antibody,Targeting In...er,Rationale for IL-9 Inhibition in Developing Pot..., 2007 /PRNewswire-FirstCall/ --,MedImmune, Inc. t...ng recent progress within the company,s inflammato...ase 1 clinical,studies with its monoclonal antibod...
Other Medicine Technology:Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
... potent naturally occurring androgen produced from...a-reductase [1]. The concentrations of 5a-reducta...uding genital skin and hair follicles, and are loc...th the nuclear membrane. DHT exerts its biologica...
Medicine Products: